Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alan J. Lewis & Anthony F. Keft. (1995) A review on the Strategies for the Development and Application of New Anti-arthritic Agents. Immunopharmacology and Immunotoxicology 17:4, pages 607-663.
Read now
Read now
Stephen Connolly & David H Robinson. (1993) Patent Update: Inhibitors of the Phospholipases A2. Current Opinion on Therapeutic Patents 3:8, pages 1141-1155.
Read now
Read now
. (1993) Patent Evaluation: Tetronic acid derivatives as PLA2 inhibitors. Current Opinion on Therapeutic Patents 3:1, pages 58-59.
Read now
Read now
. (1992) Patent Evaluation: Nonapeptide Phospholipase A2 Inhibitors. Current Opinion on Therapeutic Patents 2:10, pages 1608-1609.
Read now
Read now
Articles from other publishers (3)
Dane M. Springer, Bing-Yu Luh, Joanne J. Bronson, Katharine E. McElhone, Muzammil M. Mansuri, Kurt R. Gregor, David O. Nettleton, Paul L. Stanley & Kenneth M. Tramposch. (2000) Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity. Bioorganic & Medicinal Chemistry 8:5, pages 1087-1109.
Crossref
Crossref
Dane M. Springer, Joanne J. Bronson, Muzammil M. Mansuri, David O. Nettleton & Kenneth M. Tramposch. (1996) A simple synthesis of biaryl phospholipase A2 inhibitors: Probing hydrophobic effects. Bioorganic & Medicinal Chemistry Letters 6:22, pages 2669-2672.
Crossref
Crossref
A. Kreft, J. Nelson, J. Musser, A. Failli, U. Shah, D. Kubrak, A. Banker, R. Steffan, G. Schiehser, R. Sturm, D. Holloway, J. Bauer, M. -L. Sung, L. Marshall & K. Glaser. (1993) Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor. Agents and Actions 39:S1, pages C33-C35.
Crossref
Crossref